Skip to main content
. Author manuscript; available in PMC: 2012 Dec 3.
Published in final edited form as: Arch Ophthalmol. 2010 May 10;128(7):810–818. doi: 10.1001/archophthalmol.2010.101

Table 2.

Postoperative Adverse Events by Treatment Group

Adverse Event Treatment
CL

(57 Patients)		 IOL

(57 Patients)
Lens Reproliferation into Visual Axis 1 (2%) 24 (42%)
Pupillary Membrane 0 (0%) 17 (30%)
Corectopia 1 (2%) 11 (19%)
Glaucoma 3 (5%) 7 (12%)
Glaucoma Suspect 2 (4%) 2 (4%)
Vitreous Hemorrhage 2 (4%) 4 (7%)
Retinal Hemorrhage 2 (4%) 2 (4%)
Hyphema 1 (2%) 3 (5%)
Retained Cortex 2 (4%) 3 (5%)
Retinal Detachment 2 (4%) 0 (0%)
Endophthalmitis 1 (2%) 0 (0%)
Phthisis Bulbi 1 (2%) 0 (0%)
Contact Lens Associated Bacterial Keratitis 1 (2%) 0 (0%)
Corneal Abrasion 1 (2%) 0 (0%)
Corneal Opacity Due to Tight Contact Lens 1 (2%) 0 (0%)
Corneal Edema >30 days 0 (0%) 1 (2%)
Capsular Phimosis 1 (2%) 0 (0%)
Wound Leak / Dehiscence 0 (0%) 1 (2%)
At Least 1 Adverse Event* 14 (25%) 44 (77%)
*

Comparison of treatment groups: p-value < .0001